Frederick W. Gluck, Director at CytomX Therapeutics, Inc. (CTMX), sold 20,000 shares at $25.01 ($500K) on 2018-01-05, disclosed to the SEC on 2018-01-08.
Open-market sale of $500k CTMX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.01 | 10,000 | $250K | 50.0% |
| 2 | $25.01 | 10,000 | $250K | 50.0% |
| Total | $25.01 avg | 20,000 | $500K | 100% |
| Filing → |
| CTMX | SELL | 2018-03-02 | $115K | — | Filing → |
| CTMX | SELL | 2017-12-28 | $111K | — | Filing → |
| CTMX | SELL | 2017-10-06 | $243K | — | Filing → |